SEQENS Group

Pharmaceutical solutions & specialty ingredients

Seqens is an integrated global leader in pharmaceutical solutions and specialty ingredients, delivering outstanding performance, unrivalled market responsiveness and custom-made solutions to our customers.

A CONTINUUM OF SKILLS AND TECHNOLOGIES

Two main business activities supported by a broad range of cross-functional technologies, R&D expertise and global assets.

STRONG R&D CAPABILITIES TO DEVELOP DISTINCTIVE, CUSTOM-MADE SOLUTIONS, TO SPEED UP OUR CLIENTS’ PROJECTS BY ADDING VALUE.

• 10 state-of-the-art R&D centers in the world.

• Seqens unique range of technologies enables us to manufacture complex molecules for small- and large-scale demands

Our offer

• Custom research & innovation
• Custom development
• Custom manufacturing
• Specialty generic
• Essential APIs & intermediates
• Advanced specialties

Our History

Seqens story starts in 2003. Since then, the group has grown to become a major leader in pharmaceutical solutions and specialty ingredients.

2003 – 2011 : Consolidation of an efficient industrial base

• Creation of the Novacap Group in 2003 with Bain Capital
• First development : Launch of Isopropanol
  unit (IPA) at Roussillon

2011 – 2015 : Shift towards pharmaceutical markets

• Our first acquisitions in the Pharma space
  • Leader of Aspirin,
    APAP and PAP markets (Novacyl, Yangzi)
  • A contract manufacturer
    of Active Pharmaceutical Ingredients intermediates
    and fine chem molecules (Uetikon)
• Development of Life Science Imputs activities
  • Launch of the isopropyl acetate (IPAC) unit

2015 – 2020 : Acceleration & expansion to become an integrated pharmaceutical solutions and specialty ingredients player

• Expansion of R&D capabilities & Services 
  • Creation of the SEQENS’LAB
• Expansion of our CDMO activity
  • A contract manufacturer of Active Pharmaceutical Ingredients, intermediates and complex molecules (PCAS)
  • A contract manufacturer of Active Pharmaceutical Ingredients, intermediates, lipids and polymers (PCI Synthesis)
• Expansion of our Specialty Ingredients activities
  • A contract manufacturer of custom specialty ingredients (Chemoxy)
  • A manufacturer of Natural cosmetic ingredients (ID Bio)
• Reinforcement of Life Science Imputs activities activities
  • Launch of a new production unit for manufacturing DIPE (Diisopropyl Ether)

2021 onwards : Emergence of a leader in small molecule APIs and custom manufacturing

• Increasing our set of technologies
  and capabilities
  • HPAPI Unit at Villeneuve-la-Garenne & Aramon site
  • Flow Chem (Pilot)
  • Fermentation unit at proteus by SEQENS
  • Launch of a new unit Billingham site dedicated to the manufacture of products for the Personal Care sector
  • Launch of a new Isopropanol unit at Roussillon
• Strengthening our generic portfolio
  • Acquisition of Wavelength Pharmaceuticals a manufacturer of Active Pharmaceutical Ingredients
  • Launch of the project 12 critical molecules
  • Launch of a new Paracetamol Unit project

Our values

Driven by true entrepreneurial spirit, our success at Seqens is built on our culture of excellence that aims to provide our customers with the best product performance.

Moreover, respect and care for individuals and nature define our identity. The company always aims to provide collaborators with working conditions that are conducive to their professional development and accomplishing their goals. Attentive to the locations where we are based, Seqens is committed to local development that cares for communities and the environment.

Finally, Seqens and all of our affiliates are committed to complying with the laws and regulations (especially anti-corruption laws) that govern our activities around the world by following a strict line of conduct. Seqens aims to ensure that all persons involved in Seqens’ business relations (employees, suppliers and customers), and in particular those who are hired or act in our name, commit to complying with the legal provisions and rules defined by the Company’s Code of Conduct while conducting their activities.

Entrepreneurship

Promote initiatives to generate new ideas and opportunities and to push the organization forward. Act and be part of  the company’s success.

Unity

Ensure a positive atmosphere that encourages teamwork, mutual assistance as well as employees’ fulfillment. Promote collective objectives and successes rather than individual interests.

Customer focus

Provide best-in-class goods and services to create trusting and sustainable relationships.

Tenacity

Keep resolute and consistent despite hurdles in order to meet the objectives. Overcome challenges as a team.

Agility & reactivity

Foster rapid decisionmaking and adaptability to changing environment.